Steve Elms, Director at MAP Pharmaceuticals, Inc. (MAPP), sold 2,090 shares at $16.15 ($34K) on 2010-03-10, disclosed to the SEC on 2010-03-12.
Open-market sale of $34k MAPP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |